FDA NDC Directory · JSON-LD · Markdown

levothyroxine sodium

NDC 51655-714 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerNorthwind Health Company, LLC
Marketing categoryNew Drug Application (innovator) · App NDA021116
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (175 ug/1)
Marketing started20210526
Package count1

External sources

Source: openFDA. Public-domain (CC0).